Penn Davis McFarland’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $262K | Hold |
|
|||||
|
2023
Q1 | $233K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $258K | Hold |
|
|||||
|
2021
Q2 | $363K | Hold |
|
|||||
|
2021
Q1 | $256K | Sell |
|
|||||
|
2020
Q4 | $476K | Hold |
|
|||||
|
2020
Q3 | $375K | Hold |
|
|||||
|
2020
Q2 | $600K | Hold |
|
|||||
|
2020
Q1 | $555K | Sell |
|
|||||
|
2019
Q4 | $1.05M | Buy |
|